NASDAQ: KYNB
Kyntra Bio Inc Earnings Dates, Reports, Calls

Kyntra Bio earnings were $215.7M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest KYNB earnings report on Sep 30, 2025 announced Q3 2025 earnings of $200.6M, down 2,738.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KYNB reported annual earnings of -$47.6M, with -83.3% growth.

KYNB earnings history

Current Revenue
-$118.1M
Current Earnings
$215.7M
Current Profit Margin
-182.6%

KYNB Return on Equity

Current Company
-126.4%
Current Industry
-21.2%
Current Market
35.1%
KYNB's Return on Equity (-126.4%)... subscribe to Premium to read more.
High Return on Equity Performance

KYNB Return on Assets

Current Company
124.2%
Current Industry
-8.8%
KYNB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KYNB announces earnings.

KYNB Return on Capital Employed

Current Company
213.12%
Current Industry
-3.5%
KYNB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KYNB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KYNB$216.43M$215.65MN/A$53.48
HURA-$30.03M-$33.66M-99.75%$0.49
OTLK-$63.58M-$62.42MN/A-$1.79
OKUR-$79.78M-$81.21MN/A-$13.47
TAOX-$26.60M-$27.07MN/A-$17.06

Kyntra Bio Earnings Reports & History FAQ

What were Kyntra Bio's earnings last quarter?

Kyntra Bio (NASDAQ: KYNB) reported Q3 2025 earnings per share (EPS) of $49.61, up 1,267.29% year over year. Total KYNB earnings for the quarter were $200.64 million. In the same quarter last year, Kyntra Bio's earnings per share (EPS) was -$4.25.

If you're new to stock investing, here's how to buy Kyntra Bio stock.

Is Kyntra Bio profitable or losing money?

As of the last Kyntra Bio earnings report, Kyntra Bio is currently profitable. Kyntra Bio's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $215.65 million, a 277.07% decrease year over year.

What was KYNB's earnings growth in the past year?

As of Kyntra Bio's earnings date in Q1 2026, Kyntra Bio's earnings has grown year over year. KYNB earnings in the past year totalled $215.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.